ID

23866

Descripción

Study part: Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36/ Early Withdrawal Visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Palabras clave

Versiones (1)
  1. 15/7/17 15/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

15 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36 Mepolizumab HES NCT00086658

Inglés

Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36

1 formularios  
Serious Adverse Event (SAE)- Additional/ Follow- Up Information
Descripción

Serious Adverse Event (SAE)- Additional/ Follow- Up Information

Alias
UMLS CUI-1
C1519255
Subject ID
Descripción

Subject ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Centre Number
Descripción

Centre Number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Randomisation Number
Descripción

Randomisation Number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
SECTION 12 SAE Additional/Follow-up Information
Descripción

SAE

Tipo de datos

text

Alias
UMLS CUI [1]
C1519255
Investigator’s signature
Descripción

Investigator signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Investigator’s name
Descripción

Investigator name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Volver a la parte superior de la página

Similar models

Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Serious Adverse Event (SAE)- Additional/ Follow- Up Information
C1519255 (UMLS CUI-1)
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Randomisation Number
Item
Randomisation Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
SAE
Item
SECTION 12 SAE Additional/Follow-up Information
text
C1519255 (UMLS CUI [1])
Investigator signature
Item
Investigator’s signature
text
C2346576 (UMLS CUI [1])
Investigator name
Item
Investigator’s name
text
C2826892 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial